Posted by Amanda Lents
An Federal Drug and Food Administration Advisory Panel says companies should conduct long-term studies on the heart risks associated with diabetes drugs before they are approved.
Currently companies need to show their drug can control blood sugar in order to get approval.
However, last year a study found the diabetes drug Avandia helped blood sugar levels but possibly increased a patient's risk for heart disease.
The advisory panel said studies looking at heart risks and benefits should start before a drug is approved.